miR-539 inhibits prostate cancer progression by directly targeting SPAG5

BACKGROUND: We conducted multiple microarray datasets analyses from clinical and xenograft tumor tissues to search for disease progression-driving oncogenes in prostate cancer (PCa). Sperm-associated antigen 5 (SPAG5) attracted our attention. SPAG5 was recently identified as an oncogene participatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongtuan, Li, Shadan, Yang, Xiong, Qiao, Baomin, Zhang, Zhihong, Xu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818461/
https://www.ncbi.nlm.nih.gov/pubmed/27037000
http://dx.doi.org/10.1186/s13046-016-0337-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818461/
https://www.ncbi.nlm.nih.gov/pubmed/27037000
http://dx.doi.org/10.1186/s13046-016-0337-8

Ejemplares similares